Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-996-5 | CAS number: 689294-28-8
Endpoint summary
Administrative data
Description of key information
Additional information
No experimental, nor literature aquatic toxicity data are available on the TATD-CLE, therefore the read across approach was evaluated.
The analogues considered were Cefuroxime (EC: 259-560-1; CAS: 55268-75-2) and Ceftaroline fosamil (EC:/; CAS: 400827-46-5).
Cefuroxime was not detected in STP influent and STP and hospital effluent water in Norway[2], and this is the only monitoring conducted in the Nordic countries. Environmental data available are summarized below[1-2,3]:
- Algae S. capricornutum: EC50> 76000 μg/L (72 h) and NOEC ≥ 76000 μg/L
- Daphnia magna, EC50> 831000 μg/L (48 h) and NOEC ≥ 831000 μg/L
- Fish (Oncorhyncus mykiss), a EC50> 100000 μg/L (96 h) and a NOEL > 100000 μg/L was reported.
The PEC/PNEC for Cefuroxime was calculated to be 0.002 (N) and (S).
Environmental data available on Ceftaroline fosamil are[4]:
- Algae: Anabaena flos-aquae NOEC = 1.2 µg/L and Pseudokirch-neriella subcapitata NOEC = 33000 µg/L. Both tests were conducted according to the OECD guideline 201
- Daphnia magna: NOEC = 7900 µg/L; test conducted according to the OECD guideline 211
- Fish: NOEC = 5000 µg/L, test conducted according to the OECD guideline 210
Reference
[1]Secondary source:STF, Statens forurensningstilsyn, Oslo. Human and Veterinary Pharmaceuticals, Narcotics, and Personal Care Products in the Environment. Report 2325/2007. Project leader: Martin Schlabach Authors: Merete Grung, Eldbjørg S. Heimstad, Morten Moe, Martin Schlabach, Anders Svenson, Kevin Thomas, Andreas Woldegiorgis.
[2]Thomas, K. V., k. Langford, et al. (2007). SFT report TA-2246/2207. Occurrence of selected pharma-ceuticals in wastewater effluents from hospitals (Ullevål and Rikshospitalet) and VEAS wastewater treatment works. Oslo, SFT, NIVA and NILU: 34 pages.
[3]Läkemedelsindustriföreningen. (2007).
[4]Secondary source: EMA, Committee for Medicinal Products for Human Use (CHMP). Assessment report Zinforo. Ceftaroline fosamil. Procedure No.: EMEA/H/C/002252. 21 June 2012.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
